Skip to Content
Merck
CN

UHPLC/MS Analysis of Anticonvulsants on Ascentis® Express HILIC

UHPLC/MS Analysis of Anticonvulsants on Ascentis® Express HILIC application for UHPLC-MS

Materials

related product

Product No.
Description
Pricing

Ascentis® Express HILIC, 2.7 μm HPLC Column

2.7 μm particle size, L × I.D. 10 cm × 3 mm

Gabapentin solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Pregabalin solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Vigabatrin solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

CONDITIONS

column

Ascentis Express HILIC, 10 cm x 3.0 mm I.D., 2.7 μm particles (53970-U)

mobile phase

[A] 5 mM ammonium formate pH unadjusted in 95:5, acetonitrile:water; [B] 5 mM ammonium formate pH unadjusted in 75:25, acetonitrile:water; (25:75, A:B)

flow rate

0.4 mL/min

pressure

1240 psi (85.5 bar)

column temp.

35 °C

detector

MS-ESI-, full scan 100-500 m/z

detector

5 μL

sample

3 anticonvulsants 1 μg/mL in 99:1, acetonitrile:methanol

Description

Analysis Note

The unique selectivity of the Ascentis Express HILIC phase provided rapid LC/MS resolution of these anticonvulsant compounds. The highest grade LC-MS solvents were used to supply low background interference and low particulate contaminants for robust, trouble-free operation. Cerilliant CRMs provided reliable identification and quantification.

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany